These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14975573)

  • 21. Randomized clinical trial of homocysteine level lowering therapy and fractures.
    Sawka AM; Ray JG; Yi Q; Josse RG; Lonn E
    Arch Intern Med; 2007 Oct; 167(19):2136-9. PubMed ID: 17954810
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability.
    Lea R; Colson N; Quinlan S; Macmillan J; Griffiths L
    Pharmacogenet Genomics; 2009 Jun; 19(6):422-8. PubMed ID: 19384265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there really a power shortage in clinical trials testing the "homocysteine hypothesis?".
    Hankey GJ; Eikelboom JW; Loh K; Yi Q; Pizzi J; Tang M; Hickling S; Le M; Klijn CJ; Dusitanond P; van Bockxmeer F; Gelavis A; Baker R; Jamrozik K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e147. PubMed ID: 15297291
    [No Abstract]   [Full Text] [Related]  

  • 24. B vitamins and homocysteine.
    Harv Health Lett; 2005 Oct; 30(12):7. PubMed ID: 16283696
    [No Abstract]   [Full Text] [Related]  

  • 25. [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)].
    Strasser RH
    Internist (Berl); 2007 Mar; 48(3):327-9. PubMed ID: 17333057
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults.
    Carlsson CM; Pharo LM; Aeschlimann SE; Mitchell C; Underbakke G; Stein JH
    Am Heart J; 2004 Sep; 148(3):E11. PubMed ID: 15389247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine trials--clear outcomes for complex reasons.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(15):1629-32. PubMed ID: 16531615
    [No Abstract]   [Full Text] [Related]  

  • 28. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 29. Folic acid-based intervention in non-ST elevation acute coronary syndromes.
    Imasa MS; Gomez NT; Nevado JB
    Asian Cardiovasc Thorac Ann; 2009 Jan; 17(1):13-21. PubMed ID: 19515873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.
    Boxer AL; Kramer JH; Johnston K; Goldman J; Finley R; Miller BL
    Neurology; 2005 Apr; 64(8):1431-4. PubMed ID: 15851736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine, B vitamins, and cardiovascular disease.
    Khare A; Lopez M; Gogtay J
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16848015
    [No Abstract]   [Full Text] [Related]  

  • 32. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine, B vitamins, and cardiovascular disease.
    Refsum H; Smith AD
    N Engl J Med; 2006 Jul; 355(2):207; author reply 209-11. PubMed ID: 16848014
    [No Abstract]   [Full Text] [Related]  

  • 34. Homocysteine, B vitamins, and cardiovascular disease.
    Wang X; Demirtas H; Xu X
    N Engl J Med; 2006 Jul; 355(2):207-9; author reply 209-11. PubMed ID: 16838445
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.
    Connelly PJ; Prentice NP; Cousland G; Bonham J
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):155-60. PubMed ID: 17600848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].
    Kozłowska I
    Ann Acad Med Stetin; 2004; 50(1):87-95. PubMed ID: 16871747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hopeful for a second HOPE-2 post hoc analysis.
    Righetti M
    Nephrol Dial Transplant; 2008 Jul; 23(7):2428-9; author reply 2429-30. PubMed ID: 18403437
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of folic acid on endothelial function following acute myocardial infarction.
    Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ
    Am J Cardiol; 2007 Feb; 99(4):476-81. PubMed ID: 17293188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia.
    Spoelstra-de MA; Brouwer CB; Terheggen F; Bollen JM; Stehouwer CD; Smulders YM
    Neth J Med; 2004; 62(7):246-53. PubMed ID: 15554600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.